Jefferies Financial Group Analysts Give Fresenius Medical Care AG & Co. KGaA (ETR:FME) a €80.00 Price Target

Jefferies Financial Group set a €80.00 ($93.02) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report published on Tuesday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts also recently weighed in on FME. Barclays set a €84.00 ($97.67) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Monday, February 17th. Deutsche Bank set a €100.00 ($116.28) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Thursday, February 20th. Sanford C. Bernstein set a €74.75 ($86.92) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Tuesday, March 10th. Warburg Research set a €82.50 ($95.93) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Tuesday, February 18th. Finally, JPMorgan Chase & Co. set a €90.80 ($105.58) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Thursday, February 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and ten have issued a buy rating to the company’s stock. The company presently has a consensus rating of Buy and an average price target of €81.90 ($95.23).

Shares of Fresenius Medical Care AG & Co. KGaA stock opened at €57.54 ($66.91) on Tuesday. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €53.92 ($62.70) and a 12-month high of €81.10 ($94.30). The company has a market cap of $17.29 billion and a price-to-earnings ratio of 14.53. The company has a current ratio of 1.02, a quick ratio of 0.73 and a debt-to-equity ratio of 104.49. The company’s 50-day moving average price is €67.97 and its 200-day moving average price is €65.60.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Story: Why are percentage decliners important?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.